Journal
PRIMARY CARE DIABETES
Volume 15, Issue 2, Pages 199-207Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.pcd.2020.10.013
Keywords
Continuous glucose monitoring; CGM; Type 1 diabetes; Type 2 diabetes; Insulin; Ambulatory glucose profile; AGP
Categories
Funding
- Dexcom, Inc., San Diego, CA, USA
Ask authors/readers for more resources
Continuous glucose monitoring (CGM) has been proven to improve glycemia control and quality of life for individuals with type 1 and type 2 diabetes, but many primary care physicians are unfamiliar with interpreting and utilizing CGM data. As the adoption of this technology continues to grow, physicians will be challenged to integrate CGM into their clinical practices effectively.
Use of continuous glucose monitoring (CGM) has been shown to improve glycemia control, reduce hypoglycemia, lower glycemic variability and enhance quality of life for individuals with type 1 diabetes and type 2 diabetes. However, many primary care physicians may be unfamiliar with the how CGM data can interpreted and acted upon. As adoption of this technology continues to grow, primary care physicians will be challenged to integrate CGM into their clinical practices. This article is intended to provide clinicians with practical guidance in interpreting and utilizing CGM data with their patients. (c) 2020 Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available